FDA approves Vizz™—the first once-daily eye drop for presbyopia. Fast onset (30 mins), long-lasting (10 hrs), no myopic shift. Backed by CLARITY trials with 96% near-vision improvement. Designed for active lifestyles.
#EyeHealth #VizzDrop
Category:
Ophthalmology
-
-
CardiologyOphthalmology
Astaxanthin may decrease chronic, acute digital eye strain symptoms in children
Excerpt:
A 12-week clinical study has found that **daily astaxanthin supplementation** (4 mg) significantly reduces **digital eye strain** in children aged 10 to 14 who regularly use digital devices. Compared to placebo, children taking astaxanthin experienced a **20% decrease in chronic symptoms** and a **57% reduction in acute symptoms**. Additional improvements were observed in **depth perception, pupillary light reflex**, and **tear production**. These results suggest astaxanthin may be a promising strategy for managing **computer vision syndrome** in school-aged children, with effects noticeable as early as two weeks into use.